Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

jcelebi

New COO appointed at X4 Pharmaceuticals

June 13, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

X4 Pharmaceuticals has announced the appointment of John K. Celebi as its new chief operating officer. Celebi will bring over …
Appointment
ae

Google’s DeepMind to apply artificial intelligence technology to NHS in next five years

June 13, 2016 Medical Communications, Research and Development, Sales and Marketing DeepMind, NHS, collaboration, google, health tech

Google’s artificial intelligence company DeepMind Technologies wants to apply its machine learning technology to NHS patient data within the next …
News
humira_abbott__4

EU ombudsman calls for more transparency from AbbVie on Humira

June 10, 2016 Medical Communications, Research and Development AbbVie, EMA, EU, Humira, ombudsman

Abbvie continues to withhold details of clinical trials involving the world’s top-selling prescription medicine, Humira (adalimumab), according to the European …
News
simone_menne

Boehringer Ingelheim names Simone Menne new chief financial officer

June 10, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer Ingelheim

German drugmaker Boehringer Ingelheim has named Simone Menne as its new chief financial officer. The current CFO at Lufthansa will …
Appointment

FDA committee recommends MSD’s c. diff prevention drug

June 10, 2016 Medical Communications, Research and Development, Sales and Marketing FDA, MSD, Merck, bezlotoxumab, committee, zinplava

The US Food and Drug Administration’s (FDA) antimicrobial drugs advisory committee has voted by 10 to 5, with one abstention, …
News
merckincweb2

Merck & Co agrees to buy biotech firm Afferent for upfront $500 million in cash

June 10, 2016 Medical Communications, Sales and Marketing Afferent Pharmaceuticals, Financial, M&A, MA, Merck & Co

US drugmaker Merck & Co (NYSE: MRK) said it has agreed to buy biotech firm Afferent Pharmaceuticals for an upfront …
News

Novartis presents strong results in rare blood disorder trials

June 10, 2016 Medical Communications, Research and Development Jakavi, Novartis, Revolade, blood disorder

Novartis has released data from two late-stage trials for rare blood disorders, which showed that Javi (ruxolitinib) is superior to …
News
janssen_latest_logo_on_sign

Janssen says its immunotherapy daratumumab extends progression-free survival in combination study to treat multiple myeloma

June 10, 2016 Medical Communications, Research and Development Janssen, Phase III trials, drug trial, immunotherapy, multiple myeloma

Janssen said late-stage combination trials for its immunotherapy daratumumab increased progression-free survival for patients with multiple myeloma.  The company said …
News

Nice says Bayer’s Eylea not recommended as first-line treatment in draft recommendation

June 10, 2016 Medical Communications, Research and Development Bayer, Eylea, NICE, recommendation, regulation

The National Institute for Health and Care Excellence (Nice) in a provisional guidance said Bayer’s (ETR: BAYN) Eylea (aflibercept) is …
News

FDA targets online illegal prescription drugs sellers

June 10, 2016 Medical Communications, Sales and Marketing FDA, Ireland, illegal drug sales

The US Food and Drug Administration (FDA), in partnership with an INTERPOL-led global collaborative effort, has announced that it has …
News
cipla

India-based Cipla gets new chief financial officer

June 8, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cipla, Dr Reddy's, cfo, dr reddys

Cipla (NSE: CIPLA) has poached a top executive from Dr. Reddy’s by naming Kedar Upadhye as its new global chief …
Appointment
ascologo

Drug Pricing: Cancer drugs cost the most in US, but most unaffordable in India, China – Study

June 7, 2016 Medical Communications, Research and Development, Sales and Marketing ASCO, Drug pricing, oncology, social

Cancer drugs are less affordable in low-income countries, despite the lower retail prices, according to a study released at the …
Feature
clinical_trial_4

The Pharmafocus ASCO round-up

June 7, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ASCO, Pharmafocus

As the curtain falls on another annual ASCO (American Society of Clinical Oncology) congress, catch up on all the biggest …
Feature
novo_flag

Novo Nordisk presents positive long-term results for Saxenda

June 3, 2016 Medical Communications, Research and Development Novo Nordisk, cardiometabolic risk factors, liraglutide, saxenda, weight loss

Novo Nordisk has presented analysis covering three years of a late-stage trial for Saxenda (liarglutide 3mg) , which showed the …
News
shire_image_4

Shire completes Baxalta takeover

June 3, 2016 Medical Communications, Research and Development, Sales and Marketing Baxalta, Shire, deal, merger and acquisition, revenue, sales

UK drugmaker Shire (LSE: SHP) on Friday announced the completion of merger with rare disease specialist Baxalta (NYSE: BXLT).  The …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026